International Clinical Trial: A Phase 1, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered DF-003 Following Single Ascending Doses (Part 1) and Multiple Ascending Doses (Part 2) in Healthy Subjects

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122552) titled 'A Phase 1, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered DF-003 Following Single Ascending Doses (Part 1) and Multiple Ascending Doses (Part 2) in Healthy Subjects' on April 15.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The third xiangya hospital of Central South University

Condition: Chronic kidney disease

Intervention: SAD-C1 Cohort (Monotherapy):DF-003 capsules 60 mg (2x25 mg + 2x5 mg), single oral dose, fasting SAD-C1 Cohort (Placebo):Placebo capsules 60 mg, single oral dose, fasting S...